doi: 10.1016/0278-5846(85)90182-4
Documentation Documentation pending Use the visible proof route to confirm batch and certificate context before checkout
PE-22-28 (Mini-Spadin) blocks TREK-1 potassium channels with ~100-fold greater potency than its parent compound, demonstrating BDNF upregulation, rapid neurogenesis within 4 days, and cognitive benefits in stroke models (Djillani et al., 2017 in Frontiers in Pharmacology)
While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments
Elizabeth Rebello, one of the panelists, said during the first day of deliberation
The peptide market includes both legitimate research chemical suppliers and less scrupulous vendors selling contaminated or underdosed products